Main menu

Responsibility

climate_change

Climate Change

Pfizer has long recognized the risks posed by global climate change, such as more severe weather events and potential adverse impacts on human health.

We believe industry, government and the public all have a responsibility to address this evolving challenge. As a precautionary step, Pfizer has taken significant voluntary actions to reduce its own greenhouse gas (GHG) emissions and is transparent in how we are helping mitigate climate change and its impact.

In particular, we aim to:

Notable actions we're undertaking to meet our climate change commitments include:

  • Identifying the operating risks and business opportunities presented by a changing global climate.
  • Reaffirming publicly our commitment under “Caring for Climate”.
  • Effectively managing financial implications and opportunities in a carbon-constrained world.
  • Better understanding our carbon footprint across the value chain.
  • Improving scope 3 emission estimates and reducing them.

Recent performance achievements include:

  • Met our first GHG reduction goal by decreasing emissions more than 35% adjusted to revenue (2000 to 2007) – equivalent to 20% absolute reduction.
  • Achieved our second GHG reduction goal a year early decreasing emissions more than 20% on an absolute basis (2008-2012).

Top

Accolades and Recognition

Pfizer ranked #1 for the pharmaceutical sector on cycle 3 of Maplecroft's Climate Innovation Index US 100 (Bloomberg ticker: CI100) which represents the 100 largest US companies by free-float market capitalization.

Pfizer and the Carbon Disclosure Project (CDP)

  • 2012: Pfizer was named to the Carbon Performance Leadership Index for both the Global 500 and the S&P 500, one of only three health care companies to be recognized globally – a first for Pfizer!
  • 2011: Pfizer ranked #4 for healthcare on the CDP S&P 500 and #8 on the CDP Global 500
  • 2010: Pfizer named to CDP leadership for 4th consecutive year. Pfizer ranked #1 for healthcare on the CDP S&P 500 and #4 on the CDP Global 500
pdf

If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.